This week's View examines the relationship between clinically assessed left ventricular (LV) ejection fraction and survival in a large, heterogeneous clinical cohort, how a focused cardiac ultrasound performs in comparison to clinical assessment alone for diagnosis of LV systolic dysfunction and valvular heart disease, and the efficacy and safety of oral labetalol, nifedipine, and methyldopa for the management of severe hypertension in pregnancy.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Anemia, Antihypertensive Agents, Blood Pressure, Blood Pressure Determination, Diastole, Comorbidity, Diagnostic Imaging, Echocardiography, Echocardiography, Doppler, Electronic Health Records, Gestational Age, Heart Failure, Heart Valve Diseases, Hospitalists, Hydralazine, Hypertension, Inpatients, Labetalol, Methyldopa, Mitral Valve, Mitral Valve Insufficiency, Nifedipine, Pregnancy, Primary Prevention, Risk, Secondary Prevention, Seizures, Seizures, Students, Medical, Stroke Volume, Survival, Ultrasonography, Ventricular Dysfunction, Left, Women, Heart Valve Diseases

< Back to Listings